Income Statement Shanghai MicroPort EP MedTech Co., Ltd.

Equities

688351

CNE100005PG9

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 2026-03-13			5-day change	1st Jan Change
23.39 ^CNY	-1.27%		+1.43%	+1.04%

Feb. 11	Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Feb. 03	MicroPort EP MedTech Gets Regulatory Nod for Cardiac Imaging Catheter	MT

825c0fcd80.qW520YPW9RxSwzesJFthR6mXIbWTnbpie0l4O9ldeWk._gsvhLTmx0M7mnuVVBojNPvAbdvm_8oILyUsAo8tIFrMICeDxJOAXWeuRA

Published financial data: SHANGHAI MICROPORT EP MEDTECH CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	140M	189M	258M	320M	413M
Other Revenues, Total	1.03M	619K	2.81M	9.21M	-
Total Revenues	141M	190M	260M	329M	413M
Cost of Goods Sold, Total	39.19M	53.09M	81.13M	121M	-
Gross Profit	102M	137M	179M	209M	413M
Selling General & Admin Expenses, Total	70.58M	105M	117M	150M	-
Provision for Bad Debts	242K	205K	807K	1.35M	-
R&D Expenses	39.83M	63.01M	76.93M	91.31M	-
Other Operating Expenses	600K	970K	1.26M	2.2M	359M
Other Operating Expenses, Total	111M	169M	196M	245M	359M
Operating Income	-9.16M	-31.86M	-16.99M	-36.48M	54.64M
Interest Expense, Total	-	-463K	-719K	-1.27M	-
Interest And Investment Income	4.34M	7.66M	9.32M	16.97M	-
Net Interest Expenses	4.34M	7.2M	8.61M	15.7M	-
Currency Exchange Gains (Loss)	-487K	-225K	-1.21M	-559K	-
Other Non Operating Income (Expenses)	-97.93K	-137K	2.25M	961K	-2.4M
EBT, Excl. Unusual Items	-5.4M	-25.02M	-7.35M	-20.37M	52.24M
Gain (Loss) On Sale Of Investments	-	-2.88M	1.08M	12.19M	-
Gain (Loss) On Sale Of Assets	-	-	22.58K	-	-
Asset Writedown	-30.79K	-117K	-83.64K	-35.95K	-
Other Unusual Items	12.29M	16.05M	9.3M	13.83M	-
EBT, Incl. Unusual Items	6.86M	-11.97M	2.97M	5.61M	52.24M
Income Tax Expense	-	-	-	-78.16K	55.6K
Earnings From Continuing Operations	6.86M	-11.97M	2.97M	5.69M	52.19M
Net Income to Company	6.86M	-11.97M	2.97M	5.69M	52.19M
Net Income - (IS)	6.86M	-11.97M	2.97M	5.69M	52.19M
Net Income to Common Incl Extra Items	6.86M	-11.97M	2.97M	5.69M	52.19M
Net Income to Common Excl. Extra Items	6.86M	-11.97M	2.97M	5.69M	52.19M
Per Share Items
Net EPS - Basic	0.02	-0.03	0.01	0.01	0.11
Basic EPS - Continuing Operations	0.02	-0.03	0.01	0.01	0.11
Basic Weighted Average Shares Outstanding	383M	400M	425M	470M	471M
Net EPS - Diluted	0.02	-0.03	0.01	0.01	0.11
Diluted EPS - Continuing Operations	0.02	-0.03	0.01	0.01	0.11
Diluted Weighted Average Shares Outstanding	383M	400M	425M	470M	471M
Normalized Basic EPS	-0.01	-0.04	-0.01	-0.03	0.07
Normalized Diluted EPS	-0.01	-0.04	-0.01	-0.03	0.07
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	305K	-17.54M	-4.04M	-15.72M	75.39M
EBITA	-4.36M	-27.24M	-12.18M	-27.16M	54.64M
EBIT	-9.16M	-31.86M	-16.99M	-36.48M	54.64M
EBITDAR	2.17M	-17.53M	-	-	-
Total Revenues (As Reported)	-	-	260M	329M	-
Effective Tax Rate - (Ratio)	-	-	-	-1.39	0.11
Total Deferred Taxes	-	-	-	-78.16K	-
Normalized Net Income	-3.38M	-15.64M	-4.59M	-12.73M	32.65M
Non-Cash Pension Expense	-	-	-	3.11M	-
Supplemental Operating Expense Items
Marketing Expenses	2.61M	5.51M	5.32M	7.68M	-
Selling and Marketing Expenses	43.49M	70.75M	81.02M	109M	-
General and Administrative Expenses	25.23M	33.85M	36.17M	40.85M	-
Research And Development Expense From Footnotes	40.85M	63.01M	76.93M	91.31M	-
Net Rental Expense, Total	1.86M	7.46K	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	4.94M	8.91M	5.59M	2.83M	-
Stock-Based Comp., S&M Exp. (Total)	1.24M	2.1M	576K	-2.74M	-
Stock-Based Comp., G&A Exp. (Total)	5.6M	10.27M	5.38M	2.64M	-
Stock-Based Comp., Other (Total)	320K	470K	244K	136K	-
Total Stock-Based Compensation	12.1M	21.76M	11.79M	2.87M	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	446M	430M	585M	266M	-
Trading Asset Securities, Total	-	-	880M	1.07B	-
Total Cash And Short Term Investments	446M	430M	1.46B	1.33B	-
Accounts Receivable, Total	24.98M	26.37M	35.93M	54.96M	-
Other Receivables	563K	501K	1.57M	2.44M	-
Total Receivables	25.55M	26.87M	37.5M	57.4M	-
Inventory	34.63M	44.99M	86.98M	122M	-
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	4.03M	6.29M	7.01M	7.14M	-
Total Current Assets	510M	508M	1.6B	1.52B	-
Gross Property Plant And Equipment	75.67M	109M	144M	181M	-
Accumulated Depreciation	-20.14M	-31.81M	-45.45M	-66.86M	-
Net Property Plant And Equipment	55.53M	76.98M	98.26M	115M	-
Long-term Investments	10.46M	7.13M	2.78M	71.55M	-
Other Intangibles, Total	24.76M	20.58M	41.02M	85.88M	-
Deferred Tax Assets Long-Term	-	-	-	3.91M	-
Deferred Charges Long-Term	27.1M	55.56M	48.84M	27.53M	-
Other Long-Term Assets, Total	1.41M	157K	1.45M	599K	-
Total Assets	629M	669M	1.79B	1.82B	-
Liabilities
Accounts Payable, Total	4.21M	13.05M	21.02M	36.83M	-
Accrued Expenses, Total	26.2M	26.7M	33.51M	44.5M	-
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	-	3.73M	7.54M	9.14M	-
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	858K	1.79M	2.28M	3.4M	-
Other Current Liabilities	837K	1.44M	1.82M	2.57M	-
Total Current Liabilities	32.11M	46.71M	66.18M	96.44M	-
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	9.03M	20.19M	16.95M	-
Unearned Revenue Non Current	15.42M	19.5M	21.09M	14.17M	-
Deferred Tax Liability Non Current	-	-	-	3.69M	-
Other Non Current Liabilities	3.11M	3.97M	5.38M	6.97M	-
Total Liabilities	50.64M	79.21M	113M	138M	-
Common Stock, Total	400M	400M	471M	471M	-
Additional Paid In Capital	224M	248M	1.26B	1.26B	-
Retained Earnings	-44.99M	-58.08M	-55.11M	-49.28M	-
Total Common Equity	579M	590M	1.68B	1.69B	-
Total Equity	579M	590M	1.68B	1.69B	-
Total Liabilities And Equity	629M	669M	1.79B	1.82B	-
Supplemental Items
ECS Total Shares Outstanding on Filing Date	400M	400M	471M	471M	471M
ECS Total Common Shares Outstanding	400M	400M	471M	471M	471M
Book Value / Share	1.45	1.47	3.56	3.58	-
Tangible Book Value	554M	569M	1.63B	1.6B	-
Tangible Book Value Per Share	1.38	1.42	3.47	3.4	-
Total Debt	0	12.76M	27.73M	26.09M	-
Net Debt	-446M	-418M	-1.44B	-1.31B	-
Debt Equivalent Oper. Leases	14.91M	59.69K	-	-	-
Equity Method Investments, Total	10.46M	7.13M	2.78M	71.55M	-
Account Code - Inventory Valuation	6	6	6	6	-
Inventories - Raw Materials, Total	17.97M	22.77M	47.88M	55.78M	-
Inventories - Work In Process, Total	10.31M	13.48M	26.6M	39.43M	-
Inventories - Finished Goods, Total	6.61M	9.3M	13.37M	27.85M	-
Buildings, Total	25.63M	25.63M	25.63M	25.63M	-
Machinery, Total	45.22M	61M	76.79M	107M	-
Full Time Employees	-	-	485	577	-
Accumulated Allowance for Doubtful Accounts (Supple)	1.31M	1.39M	1.89M	2.89M	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	6.86M	-11.97M	2.97M	5.69M	-
Depreciation & Amortization - CF	4.66M	14.33M	12.14M	19.04M	-
Amortization of Goodwill and Intangible Assets - (CF)	4.8M	4.62M	4.82M	9.31M	-
Depreciation & Amortization, Total	9.46M	18.95M	16.95M	28.36M	-
Amortization of Deferred Charges, Total - (CF)	574K	1.29M	1.64M	2.98M	-
(Gain) Loss From Sale Of Asset	-	-	-22.58K	-	-
(Gain) Loss on Sale of Investments - (CF)	-1.98M	2.88M	-1.08M	-22.32M	-
Asset Writedown & Restructuring Costs	514K	816K	790K	574K	-
Stock-Based Compensation (CF)	12.1M	21.76M	-	-	-
Provision and Write-off of Bad Debts	242K	205K	807K	1.35M	-
Other Operating Activities, Total	432K	-4.36M	73.05K	765K	-
Change In Accounts Receivable	-4.33M	-7.39M	-18.95M	-24.35M	-
Change In Inventories	-12.86M	-20.3M	-47.85M	-57.72M	-
Change In Accounts Payable	-2.31M	18.81M	23.49M	23.91M	-
Change In Deferred Taxes	-	-	-	-78.16K	-
Change in Other Net Operating Assets	-	-	11.79M	2.87M	-
Cash from Operations	8.71M	20.69M	-9.38M	-37.97M	-
Capital Expenditure	-31.18M	-36.71M	-31.93M	-41.93M	-
Sale of Property, Plant, and Equipment	-	-	-	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	0	0	-877M	-258M	-
Other Investing Activities, Total	3.52M	1.72M	4.22M	25.21M	-
Cash from Investing	-27.66M	-34.99M	-905M	-275M	-
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-4.97M	-5.62M	-10.47M	-
Total Debt Repaid	-	-4.97M	-5.62M	-10.47M	-
Issuance of Common Stock	300M	-	1.08B	-	-
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-	-	-13.47M	-	-
Cash from Financing	300M	-4.97M	1.07B	-10.47M	-
Foreign Exchange Rate Adjustments	-432K	205K	646K	505K	-
Net Change in Cash	281M	-19.06M	152M	-323M	-
Supplemental Items
Cash Income Tax Paid (Refund)	7.51M	10.44M	2.57M	13.43M	-
Levered Free Cash Flow	-20.51M	-17.99M	-50.29M	-58.1M	-
Unlevered Free Cash Flow	-20.51M	-17.7M	-49.84M	-57.31M	-
Change In Net Working Capital	5.73M	3.07M	37.67M	26.79M	-
Net Debt Issued / Repaid	-	-4.97M	-5.62M	-10.47M	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-1.23	-3.07	-0.86	-1.26	-
Return on Total Capital	-1.38	-3.37	-0.92	-1.34	1.97
Return On Equity %	1.66	-2.05	0.26	0.34	3.06
Return on Common Equity	1.66	-2.05	0.26	0.34	3.06
Margin Analysis
Gross Profit Margin %	72.26	72.06	68.83	63.35	100
SG&A Margin	49.96	55.05	45.02	45.61	-
EBITDA Margin %	0.22	-9.23	-1.55	-4.78	18.25
EBITA Margin %	-3.08	-14.34	-4.68	-8.25	13.22
EBIT Margin %	-6.48	-16.77	-6.53	-11.08	13.22
Income From Continuing Operations Margin %	4.85	-6.3	1.14	1.73	12.63
Net Income Margin %	4.85	-6.3	1.14	1.73	12.63
Net Avail. For Common Margin %	4.85	-6.3	1.14	1.73	12.63
Normalized Net Income Margin	-2.39	-8.23	-1.76	-3.87	7.9
Levered Free Cash Flow Margin	-14.51	-9.47	-19.32	-17.65	-
Unlevered Free Cash Flow Margin	-14.51	-9.32	-19.14	-17.41	-
Asset Turnover
Asset Turnover	0.3	0.29	0.21	0.18	-
Fixed Assets Turnover	2.79	2.87	2.97	3.09	-
Receivables Turnover (Average Receivables)	6.04	7.38	8.27	7.04	-
Inventory Turnover (Average Inventory)	1.21	1.33	1.23	1.15	-
Short Term Liquidity
Current Ratio	15.88	10.89	24.12	15.75	-
Quick Ratio	14.68	9.79	22.7	14.41	-
Operating Cash Flow to Current Liabilities	0.27	0.44	-0.14	-0.39	-
Days Sales Outstanding (Average Receivables)	60.6	49.48	44.16	51.84	-
Days Outstanding Inventory (Average Inventory)	302.28	273.69	296.85	316.68	-
Average Days Payable Outstanding	48.63	49.66	50.51	67.65	-
Cash Conversion Cycle (Average Days)	314.26	273.51	290.5	300.87	-
Long Term Solvency
Total Debt/Equity	-	2.16	1.65	1.55	1.1
Total Debt / Total Capital	-	2.12	1.63	1.52	1.09
LT Debt/Equity	-	1.53	1.2	1.01	-
Long-Term Debt / Total Capital	-	1.5	1.19	0.99	-
Total Liabilities / Total Assets	8.05	11.84	6.31	7.58	-
EBIT / Interest Expense	-	-68.79	-23.64	-28.72	-
EBITDA / Interest Expense	-	-27.89	-0.06	-6.39	-
(EBITDA - Capex) / Interest Expense	-	-107.15	-44.48	-39.41	-
Total Debt / EBITDA	-	-0.99	-643.99	-3.21	0.25
Net Debt / EBITDA	-1.46K	32.32	33.37K	160.87	-18.02
Total Debt / (EBITDA - Capex)	-	-0.26	-0.87	-0.52	0.25
Net Debt / (EBITDA - Capex)	14.43	8.41	44.94	26.1	-18.02
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.31	34.5	36.99	26.46	25.51
Gross Profit, 1 Yr. Growth %	29.09	34.12	30.86	16.38	25.51
EBITDA, 1 Yr. Growth %	-101.85	-5.85K	-80.8	327.12	165.48
EBITA, 1 Yr. Growth %	-78.5	525.2	-54.87	129.86	222.2
EBIT, 1 Yr. Growth %	-63.49	247.94	-46.66	114.64	614.63
Earnings From Cont. Operations, 1 Yr. Growth %	-145.33	-308.54	-124.82	85.17	817.4
Net Income, 1 Yr. Growth %	-145.33	-308.54	-124.82	85.17	817.4
Normalized Net Income, 1 Yr. Growth %	-77.2	283.83	-70.63	177.24	831.16
Diluted EPS Before Extra, 1 Yr. Growth %	-142.22	-299.33	-123.41	65.75	816.53
Accounts Receivable, 1 Yr. Growth %	16.41	5.56	36.25	52.96	-
Inventory, 1 Yr. Growth %	15.06	29.91	93.32	40.71	-
Net Property, Plant and Equip., 1 Yr. Growth %	20.94	38.62	27.64	16.61	-
Total Assets, 1 Yr. Growth %	110.25	6.3	167.38	1.72	-
Tangible Book Value, 1 Yr. Growth %	152.91	2.75	187.23	-2.17	8.23
Common Equity, 1 Yr. Growth %	132.62	1.91	184.16	0.56	2.71
Cash From Operations, 1 Yr. Growth %	-5.78K	137.61	-145.33	304.77	-
Capital Expenditures, 1 Yr. Growth %	227.18	17.72	-13.04	31.33	-
Levered Free Cash Flow, 1 Yr. Growth %	91.65	-12.27	122.41	15.54	-
Unlevered Free Cash Flow, 1 Yr. Growth %	97.44	-13.68	123.28	14.98	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	29.52	27.2	35.74	31.62	25.98
Gross Profit, 2 Yr. CAGR %	35.55	31.58	32.48	23.41	51.85
EBITDA, 2 Yr. CAGR %	-55.3	3.27	264.09	-13.57	352.57
EBITA, 2 Yr. CAGR %	96.48	15.94	67.18	0.33	115.03
EBIT, 2 Yr. CAGR %	23.08	12.71	36.23	7	79.31
Earnings From Cont. Operations, 2 Yr. CAGR %	102.51	-11.03	-28.06	-31.08	312.16
Net Income, 2 Yr. CAGR %	102.51	-11.03	-28.06	-31.08	312.16
Normalized Net Income, 2 Yr. CAGR %	-18.89	2.75	6.17	-9.77	166.63
Diluted EPS Before Extra, 2 Yr. CAGR %	80.4	-16.02	-31.69	-36.39	289.77
Accounts Receivable, 2 Yr. CAGR %	0.02	10.85	19.93	44.36	-
Inventory, 2 Yr. CAGR %	16.96	22.26	58.48	64.93	-
Net Property, Plant and Equip., 2 Yr. CAGR %	23.72	29.48	33.02	22	-
Total Assets, 2 Yr. CAGR %	117.83	49.5	68.59	65.11	-
Tangible Book Value, 2 Yr. CAGR %	366.51	61.2	71.79	67.64	2.9
Common Equity, 2 Yr. CAGR %	211.23	53.97	70.17	69.05	1.63
Cash From Operations, 2 Yr. CAGR %	65.76	1.06K	3.79	35.46	-
Capital Expenditures, 2 Yr. CAGR %	313.32	96.26	1.18	6.87	-
Levered Free Cash Flow, 2 Yr. CAGR %	132.14	29.67	56.59	60.3	-
Unlevered Free Cash Flow, 2 Yr. CAGR %	99.43	30.55	55.89	60.23	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	31.64	31.16	30.39	32.57	29.55
Gross Profit, 3 Yr. CAGR %	37.59	35.07	31.34	26.88	44.5
EBITDA, 3 Yr. CAGR %	-68.14	125.65	-37.36	272.22	53.01
EBITA, 3 Yr. CAGR %	-27.54	188.99	-15.61	84.05	26.51
EBIT, 3 Yr. CAGR %	-17.68	74.03	-12.17	58.52	19.7
Earnings From Cont. Operations, 3 Yr. CAGR %	-21.97	92.74	-41.87	-0.31	63.34
Net Income, 3 Yr. CAGR %	-21.97	92.74	-41.87	-0.31	63.34
Normalized Net Income, 3 Yr. CAGR %	-32.87	44.97	-32.32	46.2	27.81
Diluted EPS Before Extra, 3 Yr. CAGR %	-55.99	75.83	-45.14	-6.91	54.79
Accounts Receivable, 3 Yr. CAGR %	-2.98	1.83	18.74	30.06	-
Inventory, 3 Yr. CAGR %	24.5	21.13	42.44	52.32	-
Net Property, Plant and Equip., 3 Yr. CAGR %	18.33	28.5	28.86	27.31	-
Total Assets, 3 Yr. CAGR %	68.4	71.5	81.47	42.57	-
Tangible Book Value, 3 Yr. CAGR %	203.54	181.73	95.43	42.4	44.89
Common Equity, 3 Yr. CAGR %	113.41	114.52	88.86	42.81	43.18
Cash From Operations, 3 Yr. CAGR %	-15.33	86.9	294.03	63.37	-
Capital Expenditures, 3 Yr. CAGR %	62.94	171.94	49.62	10.37	-
Levered Free Cash Flow, 3 Yr. CAGR %	-3.92	67.84	67.5	41.5	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-2.87	50.86	68.67	40.85	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	30.57	32.78	33.26	31.34	28.61
Gross Profit, 5 Yr. CAGR %	35.43	37.15	35.52	30.28	39.19
EBITDA, 5 Yr. CAGR %	-54.77	1.59	-15.59	59.44	35.6
EBITA, 5 Yr. CAGR %	-23.71	9.08	1.23	88.92	21.94
EBIT, 5 Yr. CAGR %	-11.84	7.92	0.69	43.26	16.85
Earnings From Cont. Operations, 5 Yr. CAGR %	-16.53	-8.39	-27.1	27.74	28.1
Net Income, 5 Yr. CAGR %	-16.53	-8.39	-27.1	27.74	28.1
Normalized Net Income, 5 Yr. CAGR %	-20.81	6.17	-16.28	19.92	17.12
Diluted EPS Before Extra, 5 Yr. CAGR %	-44.32	-35.67	-49.35	17.08	21.2
Accounts Receivable, 5 Yr. CAGR %	21.9	11.78	5.61	17.09	-
Inventory, 5 Yr. CAGR %	13.47	24.76	37.12	37.05	-
Net Property, Plant and Equip., 5 Yr. CAGR %	13.53	20.12	24	25.86	-
Total Assets, 5 Yr. CAGR %	34.97	38.94	68.48	68.91	-
Tangible Book Value, 5 Yr. CAGR %	49.23	78	141.73	128.9	51.2
Common Equity, 5 Yr. CAGR %	49.69	51.69	94.94	95.02	47.4
Cash From Operations, 5 Yr. CAGR %	-19.36	49.2	-8.15	64.32	-
Capital Expenditures, 5 Yr. CAGR %	3.67	48.95	34.67	87.17	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-19.34	16.82	72.49	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-19.31	17.37	61.87	-